Fundraising Fox
/People
Sign in

Slanix Paul Alex

Investor

President and Portfolio Manager, Public Equity at Ally Bridge Group · Partner at Montis VC

Miami, Florida, United States

Find your path to Slanix

532 people in our graph can introduce you to Slanix.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Eric Kwong to introduce you to Slanix

You →Eric · together at Ally Bridge Group (2023) →Slanix

Ask Jamie Chen to introduce you to Slanix

You →Jamie · 11 people · together at RBC Capital Markets →Slanix

Sign up to find every way you can get introduced to Slanix

  • Your email: the people you already email who know Slanix
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Slanix
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Pharm.D. who joined Ally Bridge Group in 2023 as President and Portfolio Manager of its Public Equity strategy. Previously a founding partner and senior analyst at Tri Locum Partners, an investment analyst at Consonance Capital Management, and a sell-side biotech equity research analyst at RBC Capital Markets and Credit Suisse; began his career in strategy consulting at Bionest Partners. Holds a PharmD from St John's University.

Experience

  1. Ally Bridge GroupPresident & Portfolio Manager, Public Equitycurrent2024 — presentMiami, Florida
  2. Ally Bridge GroupPortfolio Manager, Public Equity2023 — 2024New York, New York
  3. ProMIS™ Neurosciences, Inc.Member, Board of Directorscurrent2025 — presentCambridge, Massachusetts
  4. Tri Locum PartnersPartner & Senior Analyst, SMid-cap Life Sciences2020 — 2022New York, New York, United States
  5. Consonance CapitalInvestment Analyst, SMid-cap Biotech2018 — 2020New York, New York
  6. RBC Capital MarketsVP, Biotech Equity Research2017 — 2018New York, New York
  7. Credit SuisseSenior Associate, SMid-cap Biotech Equity Research2015 — 2017New York, New York
  8. Bionest PartnersAssociate Consultant2014 — 2015New York, New York
  9. AgencyRxBusiness Strategist, Strategic & Scientific Services2013 — 2014New York, New York

Colleagues at Ally Bridge Group

Andrew Lam
Managing Director, Head of Biotech Private Equity at Ally Bridge Group
Carlos Solórzano
Principal at S32
Frank Yu
Investor at Ally Bridge Group
Kevin Reilly
Managing Director and Head of MedTech Investments at Ally Bridge Group
Megan MacDonagh
Senior Associate at SV Health Investors
Steven Plachtyna
Investor at Ally Bridge Group

Frequently asked questions

Who is Slanix Paul Alex?
Pharm.D. who joined Ally Bridge Group in 2023 as President and Portfolio Manager of its Public Equity strategy. Previously a founding partner and senior analyst at Tri Locum Partners, an investment analyst at Consonance Capital Management, and a sell-side biotech equity research analyst at RBC Capital Markets and Credit Suisse; began his career in strategy consulting at Bionest Partners. Holds a PharmD from St John's University.
Where does Slanix Paul Alex work?
Slanix Paul Alex is President and Portfolio Manager, Public Equity at Ally Bridge Group.
Where did Slanix Paul Alex go to school?
Slanix Paul Alex studied at St. John's University (Doctor of Pharmacy (Pharm.D.)).

Same school

Shared employers